Jiangsu CoWin Biotech Co., Ltd. (SHA:688426)
China · Delayed Price · Currency is CNY 23.00
+0.49 (2.18%)
At close: Jul 24, 2025, 2:57 PM CST
Jiangsu CoWin Biotech Market Cap
Jiangsu CoWin Biotech has a market cap or net worth of 2.53 billion as of July 24, 2025. Its market cap has increased by 20.39% in one year.
Market Cap
2.53B
Enterprise Value
1.93B
Revenue
140.08M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.00
Market Cap Chart
Since October 25, 2022, Jiangsu CoWin Biotech's market cap has decreased from 4.06B to 2.53B, a decrease of -37.78%. That is a compound annual growth rate of -15.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2025 | 2.53B | -20.48% |
| Dec 31, 2024 | 3.18B | -7.26% |
| Dec 29, 2023 | 3.43B | 3.44% |
| Dec 30, 2022 | 3.31B | -18.44% |
| Oct 25, 2022 | 4.06B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 381.16B |
| Shenzhen Mindray Bio-Medical Electronics | 276.35B |
| WuXi AppTec | 239.63B |
| Sichuan Biokin Pharmaceutical | 124.35B |
| Zhangzhou Pientzehuang Pharmaceutical., | 123.50B |
| Aier Eye Hospital Group | 118.61B |
| Shanghai United Imaging Healthcare | 109.45B |
| Yunnan Baiyao Group Co.,Ltd | 100.86B |